Supernus Pharmaceuticals
Biopharmaceutical company developing and commercializing CNS disease treatments.
About
Technology stack
detected 2026-06-17
AWSNo comments yet. Be the first to share your take.
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products to treat central nervous system (CNS) diseases. They offer novel products designed to provide important health benefits to patients living with CNS diseases and are actively engaged in research and development of promising product candidates.
How much funding has Supernus Pharmaceuticals raised?
Supernus Pharmaceuticals has raised a total of $18M in funding. The most recent round on record is Series A.
Where is Supernus Pharmaceuticals headquartered?
Supernus Pharmaceuticals is headquartered in Rockville, United States.
When was Supernus Pharmaceuticals founded?
Supernus Pharmaceuticals was founded in 2005.
What industry does Supernus Pharmaceuticals operate in?
Supernus Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience.
How many employees does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals has approximately 809 people on record.